103 related articles for article (PubMed ID: 11773940)
1. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder.
Kamiya H; Okumura K; Ito M; Saburi Y; Tomida T; Hayashi K; Matsui H; Hayakawa T
Can J Cardiol; 2001 Dec; 17(12):1292-8. PubMed ID: 11773940
[TBL] [Abstract][Full Text] [Related]
2. [Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension].
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Yazaki Y; Nagai R; Komuro I
J Cardiol; 2001 Feb; 37(2):114-8. PubMed ID: 11255695
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
5. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
Zhou N; Li L; Wu J; Gong H; Niu Y; Sun A; Ge J; Zou Y
Biochem Biophys Res Commun; 2010 Jun; 397(2):263-9. PubMed ID: 20580688
[TBL] [Abstract][Full Text] [Related]
6. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
7. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
Jalil MA; Horiuchi M; Wakamatsu M; Li MX; Begum L; Suzuki K; Kobayashi K; Oka T; Saheki T
J Biochem; 2006 Feb; 139(2):263-70. PubMed ID: 16452314
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Kudoh S; Hiroi Y; Yazaki Y; Nagai R; Komuro I
Circulation; 2000 Oct; 102(16):1996-2004. PubMed ID: 11034951
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
11. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
13. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
Kamiya H; Okumura K; Ito M; Matsui H; Saburi Y; Hayashi K; Hayakawa T
Basic Res Cardiol; 2001 Sep; 96(5):431-8. PubMed ID: 11605989
[TBL] [Abstract][Full Text] [Related]
15. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Shimoyama M; Hayashi D; Takimoto E; Zou Y; Oka T; Uozumi H; Kudoh S; Shibasaki F; Yazaki Y; Nagai R; Komuro I
Circulation; 1999 Dec; 100(24):2449-54. PubMed ID: 10595959
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
[TBL] [Abstract][Full Text] [Related]
18. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
20. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain.
Luo J; Ma J; Yu DY; Bu F; Zhang W; Tu LH; Wei Q
Brain Res Bull; 2008 Jul; 76(5):464-8. PubMed ID: 18534252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
